| 摘要 |
The invention relates to a pharmaceutical composition having high bioavailability for oral administration of 4-[4-(3-chloro-4-methoxybenzyl-amino)benzo[4,5]thieno[2,3-d]pyrimidin-2-yl]cyclohexanecarboxylic acid and/or 4-[4-(3-chloro-4-hydroxybenzylamino)benzo[4,5]thieno[2,3-d]-pyrimidin-2-yl]cyclohexanecarboxylic acid or pharmaceutically acceptable salts thereof, to a process for the preparation of the pharmaceutical composition, and to the use thereof. |
